PharmaBoardroom

Interview: Raphael Ho – General Manager, Amgen Singapore…

With Amgen having recently reacquired the sales rights to three of its drugs, the company’s GM in Singapore and Malaysia, Raphael Ho, explains the…

Interview: Renaud Jonquieres – VP ASPAC, bioMérieux…

Renaud Jonquieres, Vice President Asia-Pacific of bioMérieux Industry, enthusiastically conveys the company’s scope and significance in the…

Interview: Dr. Thomas F. Szuran – CEO, Biomed, Switzerland

CEO of Biomed, Dr. Thomas F. Szuran discusses the keys to success for pharma SMEs and the importance of relationship management, investments, and a…

Interview: Asanga Halangoda – Director, Life Science…

Asanga Halangoda, Director of Life Science at Merck Philippines, discusses the company’s impressive recent market performance, the importance of…

Interview: Ronald Scott – CEO, Basilea, Switzerland

Ronald Scott, CEO of Basilea, a biotech company that was spun out of Roche in 2000, talks about launching its first two products, Zevtera and…

Interview: Sandra Sánchez y Oldenhage – General Manager,…

Sandra Sánchez, General Manager at PROBIOMED, explains the crucial role that biosimilars will play in the future healthcare system as well as the…

Interview: Natascha Schill – Managing Director, Biogen…

MD Natascha Schill discusses the growing importance and commitment that Biogen has to Switzerland, including a USD one billion investment in new…

Interview: Noel Heaney – General Manager,…

Noel Heaney, general manager of BMS Biologics Ireland, provides an overview of BMS in Ireland, its exciting new USD 900 million biologics facility in…

Interview: Killian O’Driscoll – Projects Director,…

NIBRT's projects director discusses the new 'Biologic' center for biologics research, business development, training, and commercializing the…

Hungary Biotech Cluster Map

Hungary's medicinal biotech companies are clustered in the country's four major university towns: Budapest, Debrecen, Szeged and Pécs, with the…

Singapore’s Recipe for Success

Singapore, though conscious of its limitations, has been able to leverage its key assets of location, infrastructure and local talent in order to…

Interview: Matt Moran – Director, BioPharmaChem, Ireland

With nearly €4 billion of capital investment in large molecule manufacturing underway, Ireland’s strategy to become a premier destination for…

Tagged with BIO